BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15055843)

  • 1. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
    Meszoely IM; Lee JS; Watson JC; Meyers M; Wang H; Hoffman JP
    Am Surg; 2004 Mar; 70(3):208-13; discussion 213-4. PubMed ID: 15055843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.
    Clark CJ; Traverso LW
    Am J Surg; 2010 May; 199(5):657-62. PubMed ID: 20466112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer.
    Yachida S; Fukushima N; Sakamoto M; Matsuno Y; Kosuge T; Hirohashi S
    Br J Surg; 2002 May; 89(5):573-8. PubMed ID: 11972546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is peritoneal cytology a predictor of unresectability in pancreatic carcinoma?
    Schmidt J; Fraunhofer S; Fleisch M; Zirngibl H
    Hepatogastroenterology; 2004; 51(60):1827-31. PubMed ID: 15532836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancer.
    Eguchi H; Ohigashi H; Takahashi H; Yano M; Motoori M; Miyashiro I; Kishi K; Ohue M; Noura S; Seki Y; Yamada T; Goto K; Yamamoto T; Idota A; Fujii J; Nakajima H; Yamasaki T; Ishikawa O
    Surgery; 2009 Nov; 146(5):888-95. PubMed ID: 19744431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection.
    Noura S; Ohue M; Seki Y; Yano M; Ishikawa O; Kameyama M
    Dis Colon Rectum; 2009 Jul; 52(7):1312-20. PubMed ID: 19571710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?
    Ishikawa O; Wada H; Ohigashi H; Doki Y; Yokoyama S; Noura S; Yamada T; Sasaki Y; Imaoka S; Kasugai T; Matsunaga T; Takenaka A; Nakaizumi A
    Ann Surg; 2003 Jul; 238(1):103-10. PubMed ID: 12832972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection.
    Bentrem D; Wilton A; Mazumdar M; Brennan M; Coit D
    Ann Surg Oncol; 2005 May; 12(5):347-53. PubMed ID: 15915368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Hoffman JP
    Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
    Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of fine-needle aspiration in patients with resectable pancreatic cancer.
    Johnson DE; Pendurthi TK; Balshem AM; Ross E; Litwin S; Eisenberg BL; Hoffman JP
    Am Surg; 1997 Aug; 63(8):675-9; discussion 679-80. PubMed ID: 9247432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer.
    Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D
    Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
    Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
    Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
    Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
    Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer.
    Boggi U; Del Chiaro M; Croce C; Vistoli F; Signori S; Moretto C; Amorese G; Mazzeo S; Cappelli C; Campani D; Mosca F
    Surgery; 2009 Nov; 146(5):869-81. PubMed ID: 19744432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal washings cytology combined with immunocytochemical staining in pancreatic cancer.
    Nakao A; Oshima K; Takeda S; Kaneko T; Kanazumi N; Inoue S; Nomoto S; Kawase Y; Kasuya H
    Hepatogastroenterology; 1999; 46(29):2974-7. PubMed ID: 10576385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.